Navigation Links
Biotech Pioneer Discusses Breakthrough in Osteoporosis Treatment

Deltanoid founder and CEO Hector DeLuca has discovered and characterized a promising chemically modified Vitamin D compound, 2MD, which reverses the effects of osteoporosis. In animal studies, 2MD increases bone growth while leaving blood calcium levels unchanged even at doses 3,000 times the level of other compounds.

According to DeLuca, Vitamin Ds main job is to regulate calcium levels......

Full article >>> s willing to acquire rights for technologies in very early stages of development. They now want to see proof of principle and more developed products before they agree to deals, he said.

As a result, Deltanoids strategy will focus on developing university technology to the stage where large pharmaceutical companies are then willing to sign on. Deltanoid will not market drugs or take them......

Full article >>>
'"/>

Source:wistechnology.com By John Keach 04/15/03


Related biology technology :

1. Biotech officials praise focus of new venture fund
2. Biotech executive books a career flight thats closer to home
3. Gala Biotech among companies sold for $3.3 billion
4. Biotech with Madison ties raises $21M in capital
5. Biotech firm uses live heart tissue in drug screens
6. Biotech talent drew venture-funded firm to Madison
7. Biotech firm has strokes, Alzheimers in its sights
8. 42 days until the 2006 Olympics of Biotechnology in Chicago
9. Biotech crops gaining acceptance, but their full promise has yet to be fulfilled
10. Biotech leads list of top U.S. companies to work for
11. Biotech flourishes in 2005 while Big Pharma is on the decline
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2017)... ... 2017 , ... Optofluidics today announced that it's changing its ... changed focus to making analytical tools for biopharmaceutical quality control. “We are excited ... Robert Hart. Founders Bernardo Cordovez, Robert Hart and David Erickson have steered the ...
(Date:4/19/2017)... (PRWEB) , ... April 19, 2017 , ... ... Clostridium difficile (C. diff) infections through education and advocacy. Founded in 2010 ... to a C. diff infection, the foundation has become the most-consulted source for ...
(Date:4/19/2017)... , April 19, 2017  As a ... and Heroin Summit ,  Proove® Biosciences, Inc. ... genetics, environmental, and lifestyle factors to accurately predict ... University of Southern California (USC), the Interventional Pain ... Proove publish results showing that Proove Opioid Risk® ...
(Date:4/19/2017)... WALTHAM, Mass. , April 19, 2017 /PRNewswire/ ... that results from the multi-center Procalcitonin MOnitoring SEpsis ... 2017 print issue of Critical Care Medicine ... Predicts Mortality in Severe Sepsis Patients: Results From ... the use of the B·R·A·H·M·S PCT (procalcitonin) assay ...
Breaking Biology Technology:
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/28/2017)... India , March 28, 2017 ... IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software ... Vertical, and Region - Global Forecast to 2022", published ... Billion in 2016 and is projected to reach USD ... between 2017 and 2022. The base year considered for ...
(Date:3/23/2017)... DUBLIN , Mar. 23, 2017 Research ... Anti-Theft System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 8.8% over the next ... This industry report analyzes the market estimates and forecasts for all ...
Breaking Biology News(10 mins):